Top Clinical Trials companies in Singapore by Return on Capital Employed (ROCE)

This ranking features the top 2 Clinical Trials companies in Singapore ranked by Return on Capital Employed (ROCE), averaging a Return on Capital Employed (ROCE) of -42.59%, for February 08, 2025.

Singapore

Clinical Trials
Return on Capital Employed (ROCE)
#
Name
Return on Capital Employed (ROCE)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
950210.KS

Prestige BioPharma Limited

1

950210.KS
-8.36%
June 30, 2024 USD 10.41 0.13%

Singapore
2
WVE

Wave Life Sciences Ltd.

2

WVE
-76.82%
Dec. 31, 2023 USD 11.57 -4.06%

Singapore
Frequently Asked Questions
  • Which Clinical Trials company in Singapore has the highest Return on Capital Employed (ROCE) ?

    The Clinical Trials company in Singapore with the highest Return on Capital Employed (ROCE) is Prestige BioPharma Limited (KSE: 950210.KS) at -8.36%.

  • Which Clinical Trials company in Singapore has the lowest Return on Capital Employed (ROCE) ?

    The Clinical Trials company in Singapore with the lowest Return on Capital Employed (ROCE) is Wave Life Sciences Ltd. (NasdaqGM: WVE) at -76.82%.

  • What are the top 10 Clinical Trials companies in Singapore by Return on Capital Employed (ROCE) ?

    The top 10 Clinical Trials companies in Singapore by Return on Capital Employed (ROCE) are Prestige BioPharma Limited and Wave Life Sciences Ltd..

  • What are the bottom 10 Clinical Trials companies in Singapore by Return on Capital Employed (ROCE) ?

    The bottom 10 Clinical Trials companies in Singapore by Return on Capital Employed (ROCE) are Wave Life Sciences Ltd. and Prestige BioPharma Limited.

SV Wall Street